BAM
GOSS icon

Belpointe Asset Management’s Gossamer Bio GOSS Stock Holding History

Belpointe Asset Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-4,000
Closed -$8.68K – 3778
2022
Q4 		$8.68K Buy
+4,000
New +$32.9K ﹤0.01% 2696

Other funds holding GOSS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Belpointe Asset Management's GOSS Position: Q1 2023 in Review

Belpointe Asset Management sold out of Gossamer Bio (GOSS) in Q1 2023, closing a stake of 4,000 shares — an estimated $8.68K sold.

Belpointe Asset Management first reported a position in GOSS in Q4 2022 and held it in 1 quarter. The position peaked at $8.68K in Q4 2022. 111 funds tracked by Wall St. Rank hold GOSS as of Q1 2023.

  • Belpointe Asset Management reported no remaining Gossamer Bio position as of Q1 2023 after selling out during the quarter.
  • Belpointe Asset Management sold 4,000 Gossamer Bio shares in Q1 2023, an estimated $8.68K.
  • Belpointe Asset Management first reported a position in Gossamer Bio in Q4 2022 and held it in 1 quarter.
  • Belpointe Asset Management's Gossamer Bio position peaked at $8.68K in Q4 2022.
  • 111 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2023.

Based on Belpointe Asset Management's 13F filing for Q1 2023, filed 15 May 2023.